Anger Clinical Trials

12 recruiting

Anger Trials at a Glance

32 actively recruiting trials for anger are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Boston, Houston, and Baltimore. Lead sponsors running anger studies include West China Second University Hospital, VA Office of Research and Development, and Assistance Publique - Hôpitaux de Paris.

Browse anger trials by phase

Treatments under study

About Anger Clinical Trials

Looking for clinical trials for Anger? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anger trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anger clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 32 trials

Recruiting
Phase 2

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Recurrent Langerhans Cell HistiocytosisRefractory Langerhans Cell Histiocytosis
National Cancer Institute (NCI)48 enrolled117 locationsNCT05828069
Recruiting
Phase 2

Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib

Langerhans Cell Histiocytosis
Cook Children's Health Care System75 enrolled1 locationNCT06582745
Recruiting
Not Applicable

Treatment of Chronic Anger and Aggression Following Military-Related Betrayal

AggressionAnger Problems
The University of Texas Health Science Center at San Antonio40 enrolled1 locationNCT06609330
Recruiting
Not Applicable

Step-by-Step: Evaluation of a Stepped Care Model

AggressionDisruptive BehaviorAnger+3 more
Karolinska Institutet210 enrolled1 locationNCT06902649
Recruiting
Not Applicable

A Mixed Methods Pilot Trial of the STEP Home Workshop to Improve Reintegration and Reduce Suicide Risk for Recently Transitioned Veterans

PTSDVeteransTBI+3 more
VA Office of Research and Development120 enrolled1 locationNCT05995678
Recruiting

Project: Every Child for Younger Patients With Cancer

Malignant Solid NeoplasmNeuroendocrine NeoplasmCentral Nervous System Neoplasm+15 more
Children's Oncology Group75,000 enrolled278 locationsNCT02402244
Recruiting
Not Applicable

Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis

Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital120 enrolled11 locationsNCT07431060
Recruiting
Not Applicable

Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions

Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital62 enrolled11 locationsNCT07371182
Recruiting
Not Applicable

Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms

Sleep DisturbancePTSDEmotional Regulation+12 more
Walter Reed National Military Medical Center40 enrolled2 locationsNCT05414708
Recruiting
Not Applicable

Parent Management Training to Treat Irritability

AngerIrritable MoodTemper Tantrum
University of Colorado, Denver36 enrolled1 locationNCT06020261
Recruiting
Not Applicable

THE MYOFASCIAL SYSTEM AND MINIMIZING THE RISK OS INJURY IN SPORT

Muscle StiffnessSports InjuriesFlexibility+6 more
Aveiro University65 enrolled1 locationNCT06895720
Recruiting
Not Applicable

Mobile Anger Reduction Intervention

AngerPosttraumatic Stress Disorder
VA Office of Research and Development150 enrolled1 locationNCT06094933
Recruiting
Phase 1

Q702 for the Treatment of Patients With Hematologic Malignancies

Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more
Mayo Clinic46 enrolled2 locationsNCT06712810
Recruiting
Phase 2

Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH

Langerhans Cell Histiocytosis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT07187193
Recruiting
Phase 2

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Langerhan's Cell HistiocytosisJuvenile XanthogranulomaErdheim-Chester Disease+4 more
Carl Allen90 enrolled12 locationsNCT04079179
Recruiting
Phase 2

Mirdametinib in Histiocytic Disorders

Histiocytic DisordersRosai-Dorfman Disease (RDD)Langerhans Cell Histiocytosis (LCH)+1 more
Children's Hospital Medical Center, Cincinnati40 enrolled1 locationNCT06153173
Recruiting
Phase 3

Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Langerhans Cell Histiocytosis
Baylor College of Medicine124 enrolled11 locationsNCT02670707
Recruiting
Not Applicable

Building Emotional Awareness and Mental Health (BEAM) 2024-2027

Depression, AnxietyStress, PsychologicalChild Development+3 more
Leslie E. Roos400 enrolled1 locationNCT06455397
Recruiting
Not Applicable

Advancing Family Wellbeing Through a Massive Open Online Intervention: The LightBEAM Program

Depression, AnxietyParentingAnger
University of Manitoba300 enrolled1 locationNCT07026838
Recruiting
Phase 2

Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children

Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital20 enrolled1 locationNCT07022834